Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. is poised for growth, supported by a projected 12.5% increase in operating expenses alongside the anticipation of achieving positive EBITDA by 2026. The company is experiencing momentum in its market presence, highlighted by a 42% two-year revenue growth in the U.S. and an increase in procedures per physician, indicating a strengthened demand for its minimally invasive surgical implant systems. With a robust net cash balance of $110 million as of 3Q25, SI-BONE is well-positioned to capitalize on growth opportunities in the underpenetrated SI joint fusion market, particularly with the adoption of its innovative product offerings like iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite.

Bears say

The financial analysis of SI-BONE Inc. indicates several factors contributing to a negative outlook. The company is experiencing a projected decline in gross margin to 78% due to pricing pressures stemming from a shift in procedure mix towards lower-average selling price (ASP) deformity and trauma cases. Additionally, revenue growth is anticipated to be low-teens domestically, coupled with continued weakness in international markets, which raises concerns about overall profitability amid competitive threats and potential patent expirations.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.